Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study |
Atherosclerotic Vascular Disease, Heterozygous Familial Hypercholesterolemia | Spain | NCT06958315 | |
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD |
Atherosclerotic Cardiovascular Disease (ASCVD) | Phase3 | China Hong Kong Puerto Rico Taiwan United Kingdom United States View all |
NCT06813911 |
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib |
Hematologic Malignancy, Solid Tumor, Advanced Malignancies | Phase3 | Belgium Italy Netherlands United Kingdom United States View all |
NCT06401356 |
Home Reported Outcomes in C3G Study |
C3 Glomerulopathy | United States | NCT07029542 | |
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) |
Metastatic Hormone-sensitive Prostate Cancer | Phase2 | Australia Canada China Czechia France Germany Italy Netherlands Poland Singapore South Korea Spain Taiwan United States View all |
NCT06991556 |
Post Marketing Study on Pluvicto in Korea |
Metastatic Castration-resistant Prostate Cancer | South Korea | NCT06514521 | |
A Multi-center, Ambispective Cohort Study to Evaluate the Impact of Iptacopan for Adult Patients With PNH in China |
Paroxysmal Nocturnal Hemoglobinuria | China | NCT06931691 | |
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis |
Atopic Dermatitis | Phase2 | Argentina Canada China Czechia France Germany Hungary Italy Japan Netherlands Poland Slovakia South Korea Spain Taiwan United Kingdom United States View all |
NCT06947993 |
Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension) |
Lupus Nephritis | Phase3 | China Colombia Hungary Mexico Singapore South Korea Taiwan Thailand View all |
NCT06711887 |
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET |
Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) | Phase3 | Canada China France Germany Hungary Italy Netherlands Poland South Korea Spain United Kingdom United States View all |
NCT06784752 |